Tesamorelin should always be viewed as one component of a comprehensive wellness programnot a standalone solution
Starting at 2 mg instead of 4 mg significantly reduced early GI symptoms
Our case series findings support previous studies that reported successful management of RH with GLP-1 analogues in post-bariatric patients ( In addition to the clinical benefits observed in our case series with pharmacological treatment, we observed a reduction in C-peptide and insulin levels in repeat MMTTs in three patients
The rise in the use of GLP1 RA may partly stem from updates in guidelines and more in general due to emerging evidence of cardiorenal benefits of GLP1 RA
The India advantage India is emerging as a preferred hub for both pharma and medical devices, offering a strategic advantage in the GLP-1 race
Thiazolidinediones (TZDs), which are known to activate PPAR-, are able to improve insulin signaling and glucose uptake by adipose tissue, despite also resulting in side effects, such as obesity [21]